BMS Media Hub

The British Menopause Society is the specialist authority for menopause and post reproductive health in the UK. Established in 1989, the BMS educates, informs and guides healthcare professionals, working in both primary and secondary care, on menopause and all aspects of post reproductive health.

Media enquiries

Members of our board of trustees and medical advisory council are leading specialists in menopause and post-reproductive healthcare and are happy to provide clinical comment.

MEDICAL/HEALTH PRESS

If you are planning a health article or piece for healthcare professionals and looking for a specialist comment, please get in touch with us via our contact form:

Below are other menopause resources you may find helpful.

CONSUMER PRESS

If your article/enquiry is for a consumer audience, please use our consumer media contact form on the Women’s Health Concern website.

Women’s Health Concern is our patient arm and on that website you can find up-to-date information, leaflets and factsheets for a consumer audience on a number of conditions such as the menopause, endometriosis, PMS, cervical and ovarian cancer and many more, which can be downloaded from our WHC factsheets and other helpful resources page.

Current issues, hot media topics and press statements

Early and premature menopause associated with increased cardiovascular risk, major global study confirms

A large multinational cohort study published in Lancet Obstetrics, Gynaecology & Women’s Health (Marschner et al., 2026) followed 111,619 women across 26 countries over a median of 14.6 years.

Premature and early menopause were consistently associated with a greater risk of major cardiovascular events, including myocardial infarction, fatal cardiovascular disease, and stroke, across all regions and ethnic groups studied.

Mr Haitham Hamoda, British Menopause Society, said women with premature and early menopause had approximately a 30% greater risk of major cardiovascular events after adjusting for risk factors. Professor Janice Rymer, BMS Chair, said the findings confirm the need to identify these women and proactively manage modifiable cardiovascular risk factors.

Read the full study: Early menopause and its association with cardiovascular outcomes (PURE): a multinational prospective cohort study

New BMS Tool for Clinicians: Menopausal ‘brain fog’ or dementia?

Cognitive symptoms such as memory lapses and difficulty concentrating are frequently reported during perimenopause and menopause, and can prompt concern about dementia.

This new BMS Tool provides evidence-based guidance to help clinicians differentiate menopausal cognitive symptoms from early neurodegenerative disease, and highlights that sleep, stress, and other health conditions may also contribute.

Menopausal ‘brain fog’ or dementia? – a practical guide for clinicians

Updated dose tables for estrogen and progestogen prescribing in BMS and WHC resources

Based on a BMS consensus review of current evidence, the following resources have been updated to ensure consistency in the tables detailing approximate equivalent estrogen doses and the suggested progestogen doses per licensed estrogen dose when prescribing progestogen and estrogen separately:

BMS joint guideline on the management of unscheduled bleeding on HRT

BMS Tool for Clinicians: HRT – Practical prescribing

WHC Fact Sheet: HRT – types, doses and regimens

WHC Fact Sheet: Management of unscheduled bleeding on HRT

Read the BMS news alert: Updated dose tables for estrogen and progestogen prescribing in BMS and WHC resources

Further information: BMS Tool for Clinicians on Progestogens and endometrial protection

Misinformation about perimenopause on social media ‘putting women at risk’

A recent article in The Guardian, featuring Dr Paula Briggs, BMS trustee, highlighted concerns that misinformation about perimenopause on social media may be putting women at risk of unintended pregnancies, unnecessary medication, and missed diagnoses.

This issue was also addressed during a lecture by Dr James Larkin on misinformation online at the BMS 35th Annual Scientific Conference. The Society continues to encourage healthcare professionals to remain alert to the impact of misinformation on patient understanding and behaviour.

Read The Guardian article: Misinformation about perimenopause on social media ‘putting women at risk’

Useful menopause resources

Key documents

Latest news

Women’s Health Concern 36th Annual Symposium brings together multidisciplinary specialists in menopause and post reproductive health

29 October 2026|Comments Off on Women’s Health Concern 36th Annual Symposium brings together multidisciplinary specialists in menopause and post reproductive health

The WHC 36th Annual Symposium took place in London on Tuesday 13 October, bringing together GPs, nurses, specialists and allied health professionals working in menopause and post reproductive health. The programme was multidisciplinary, with [...]

British Menopause Society Management of the Menopause Certificate shortlisted for Learning Awards 2027

22 October 2026|Comments Off on British Menopause Society Management of the Menopause Certificate shortlisted for Learning Awards 2027

The British Menopause Society (BMS) Management of the Menopause Certificate (MMC) has been shortlisted in the People Development Programme of the Year – Public Sector category at the Learning Awards 2027, in partnership with [...]

Survey invites clinicians to share views on menopause care after cancer

22 October 2026|Comments Off on Survey invites clinicians to share views on menopause care after cancer

Menopause and Cancer, a non-profit organisation supporting cancer survivors experiencing treatment-induced menopause is conducting a survey on menopause care after cancer. Menopause care after cancer is clinically complex, and evidence suggests that many women [...]

Mr Paul Simpson appointed Chair of the British Menopause Society

8 October 2026|Comments Off on Mr Paul Simpson appointed Chair of the British Menopause Society

The British Menopause Society (BMS) board of trustees is pleased to announce that Mr Paul Simpson has taken up his position as Chair. He assumed office at the end of the BMS Annual General [...]

Nationwide Danish study reaffirms benefits and risks of menopausal hormone therapy by route of administration

24 September 2026|Comments Off on Nationwide Danish study reaffirms benefits and risks of menopausal hormone therapy by route of administration

A large nationwide case-control study from Denmark, published this month, examines associations between current use of menopausal hormone therapy (MHT) and risk of venous thromboembolism (VTE), ischaemic stroke, and myocardial infarction (MI).MHT remains an effective [...]

Press announcements

Media statement: BMS response to new study published in The BMJ: Certain HRT tablets linked to increased heart disease and blood clot risk
28 November 2024
The British Menopause Society has published the following response to a new study published in The BMJ.
Media statement: BMS statement in response to the publication of the updated NICE Menopause guideline (NG23)
7 November 2024
The publication today of the reviewed NICE guideline Menopause: identification and management (NG23) marks an important development in the diagnosis and treatment of menopausal women.